PILGRIM - Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus Type II
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Insulin aspart (Primary) ; Liraglutide (Primary) ; Glucose; Insulin; Potassium chloride
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms PILGRIM
- 23 Jan 2017 Status changed from recruiting to completed.
- 08 Aug 2016 Planned number of patients changed from 315 to 150.
- 05 Feb 2016 Planned End Date changed from 1 Mar 2016 to 1 Mar 2017 as per ClinicalTrials.gov record.